Prediction of hormone sensitivity - The receptor years and onwards

Endocrine-Related Cancer

Volumn 4, Issue 3, 1997, Pages 289-296

  Leake, R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

BREAST CANCER; DRUG SENSITIVITY; FEMALE; HORMONAL THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; REVIEW;

EID: 0030807491     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0040289     Document Type: Review

References (64)

1. Allegra JC, Lippman, ME, Simon R, Thompson EB, Barlock A & Green L 1979 Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treatment Reports 63 1271-1277.
2. Andersen J & Poulsen HS 1989 Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer. Cancer 64 1901-1908.
3. Barnes DM, Skinner LG & Ribiero GG 1979 Triple hormone receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer? British Journal of Cancer 40 862-865.
4. Beatson GT 1896 On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii 104-107 and 162-165.
5. Beex LVAM, Benraad THJ & Leake RE 1989 Who needs steroid receptor assays? Lancet ii 40.
6. Boyle P & Leake RE 1988 Biological-epidemiological interactions in the understanding of breast cancer. Breast Cancer Treatment and Research 11 91-112.
7. Butler JA, Bretsky S, Menendez-Boty C & Kinne DW 1985 Estrogen receptor protein of breast cancer as a predictor of recurrence. Cancer 55 1178-1181.
8. Castagnetta L, Traina A, Di Carlo A, Latteri AM, Carruba G & Leake RE 1987 Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancer. European Journal of Cancer and Clinical Oncology 23 31-35.
9. Castagnetta L, Traina A, Di Carlo A, Carruba G, Lo Casto M, Mesiti M & Leake R 1989 Do multiple oestrogen receptor assays give significant additional information for the management of breast cancer? British Journal of Cancer 59 636-638.
10. Clark CM, Maguire WL, Hubay CA, Pearson OH & Marshal JS 1983 Progesterone receptors as a prognostic factor in Stage II breast cancer. New England Journal of Medicine 309 1343-1347.
11. Crawford D, Cowan S, Hyder S, McMenamin M, Smith D & Leake R 1984 New storage procedure for human tumor biopsies prior to estrogen receptor measurement. Cancer Research 44 2348-2351.
12. Crawford DJ, Lope-Pihie A, Cowan S, George WD & Leake RE 1985 Pre-operative determination of oestrogen receptor status by immunocytochemical staining of fine needle aspirates. British Journal of Surgery 243 991-993.
13. Crawford DJ, Cowan S, Fitch R, Smith DC & Leake RE 1987 Stability of oestrogen receptor status in sequential biopsies from patients with breast cancer. British Journal of Cancer 56 137-140.
14. Crawford DJ, George WD, Smith DC, Stewart M, Paul J & Leake RE 1992 Comparison of cyclical tamoxifen and megestrol acetate with tamoxifen alone in advanced breast cancer. The Breast 1 35-40.
15. Dickson RB, Low JA, Johnson MD, Hawkins MJ & Trock BJ 1996 Bloodborne indicators of breast cancer and their use in experimental, medical, oncological and prevention studies. The Breast 5 379-384.
16. Early Breast Cancer Trialists' Collaborative Group 1992 Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339 1-15.
17. Evans DG 1996 Genetic markers for breast cancer. The Breast 5 374-376.
18. Fisher B, Redmond C, Brown A, Wickerhan DL, Wolmark N, Allegra J, Escher G, Lippman M, Savlov E, Wittliff J & Fisher ER 1983 Influence of tumour estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. Journal of Clinical Oncology 1 227-241.
19. Forrest APM, Hawkins RA, Anderson EDC, Chetty C & Stewart HJ 1989 Who needs steroid receptor assays? Lancet ii 40.
20. Graham DM, Jin L & Lloyd RV 1991 Detection of estrogen receptor in paraffin-embedded sections of breast carcinoma by immunohistochemistry and in situ hybridization. American Journal of Surgery and Pathology 15 475-485.
21. Hawariah LPA & Leake RE 1990 Intratumoral variation of estrogen receptor concentrations in fine needle aspirates of human breast cancer using immunofluorescence techniques. In Protein Structure and Function, pp 215-224. Eds M Zaidi, A Abbassi & DL Smith. Kuala Lumpur: TWEL Publishers.
22. Hawkins RA 1993 Prognostic factors: seeking a shaft of light or getting lost in the woods? The Breast 2 125-129.
23. Hawkins RA, Roberts MM & Forrest APM 1980 Oestrogen receptors and breast cancer: current status. British Journal of Surgery 6 153-169.
24. Hilf R, Feldstein ML, Gibson SL & Savlov E 1980 The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer 45 1993-2000.
25. Howat JMT, Harris M, Swindell R & Barnes DM 1985 The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. British Journal of Cancer 51 263-270.
26. Howell A, Harland RNL, Barnes DM, Baildam AD, Wilkinson MJS, Haward E, Swindell R & Sellwood RA 1987 Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment. Cancer Research 47 300-304.
27. Howell, A, DeFriend D & Anderson E 1993 Mechanisms of response and resistance to endocrine therapy for breast cancer and the development of new treatments. Reviews on Endocrine-Related Cancer 43 5-21.
28. Ismail SM, Thomas GA, Ghandour FA, Davies HG, Attanos R & Williams ED 1992 Oestrogen receptor protein and mRNA in adenocarcinoma of the uterine cervix. British Journal of Cancer 66 1150-1154.
29. Jensen EV 1992 Remembrance: Gregory Pincus - Catalyst for early receptor studies. Endocrinology 131 1581-1582.
30. Jensen V & Andersen J 1996 Value of immunohistochemical-determined oestrogen receptor status and proliferative activity in breast cancer: a retrospective study including patients treated by endocrine therapy at the time of recurrence. The Breast 5 127-134.
31. Jensen EV, Jacobson HI, Flesher JW, Saha NN, Gupta GN, Smith S, Colucci V, Shiplacoff D, Neumann HG, DeSombre ER & Jungblut PW 1966 Estrogen receptors in target tissues. In Steroid Dynamics, pp 133-156. Eds G Pincus, T Nakao & JF Tait. New York: Academic Press.
32. King RJB, Barnes DM, Hawkins RA, Leake RE, Maynard PV & Roberts MM 1978 Measurement of oestradiol receptors by five institutions on common tissue samples. British Journal of Cancer 38 428-430.
33. Knight WA III, Livingstone RB, Gregory EJ & Maguire WL 1977 Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Research 37 4660-4671.
34. Koenders A & Thorpe S 1983 Standardisation of steroid receptor assays in human breast cancer II. European Journal of Cancer and Clinical Oncology 19 1467-1472.
35. Koji T & Brenner RM 1993 Localization of estrogen receptor mRNA in rhesus monkey uterus by nonradioactive in situ hybridization with digoxigenin-labelled oligodeoxynucleotides. Endocrinology 132 382-392.
36. Laing L, Smith DC, Calman K & Leake R 1976 Oestrogen-binding protein in plasma of breast cancer patients. Lancet ii 745.
37. Laing L, Smith MG, Calman KC, Smith DC & Leake RE 1977 Nuclear oestrogen receptors and treatment of breast cancer. Lancet ii 168-169.
38. Leake RE 1981 Steroid receptor assays in the management of endocrine disorders. Ligand Review 3 23-35.
39. Leake RE 1996 100 years of the endocrine battle against breast cancer. Lancet 347 1780-1781.
40. Leake RE, Laing L & Smith DC 1979 The role of oestradiol nuclear receptor measurements in the management of human breast cancer. In Steroid Receptor Assays in Human Breast Tumours: Methodological and Clinical Aspects, pp 9-18. Ed RJB King. Cardiff: Alpha Omega Press.
41. Leake RE, Laing L, Calman KC, Macbeth FR, Crawford D & Smith DC 1981a Oestrogen receptor status and endocrine therapy of breast cancer: response rates and status stability. British Journal of Cancer 43 59-66.
42. Leake RE, Laing L, McCardle C & Smith DC 1981b Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis. British Journal of Cancer 43 66-71.
43. Love CA, Cowan SK, Laing L & Leake RE 1983 Stability of the human nuclear oestrogen receptor: Influence of temperature and ionic strength. British Journal of Cancer 43 66-71.
44. McCarty KS, Miller LS, Cox EB, Konrath J & McCarty KS 1985 Oestrogen receptor analysis: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Archives of Pathology and Laboratory Medicine 109 716-721.
45. McClelland RA, Finlay P, Walker KJ, Nicholson D, Robertson JF, Blamey RW & Nicholson RI 1990 Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Research 50 3545-3550.
46. Maguire WL 1986 Prognostic factors in primary breast cancer. Cancer Surveys 5 527-536.
47. Maguire WL, Chamness GC & Fuqua SAW 1991 Estrogen receptor variants in clinical breast cancer. Molecular Endocrinology 5 1571-1577.
48. Manni A, Jrujillo JE, Marchall JS, Brodkey J & Pearson OH 1979 Anti-hormone treatment of Stage IV breast cancer. Cancer 43 444-452.
49. Millis RR, Bobrow LG & Barnes DM 1996 Immunohistochemical evaluation of biological markers in mammary cancer in situ: correlation with morphological features and recently proposed schemes for histological classification. The Breast 5 113-122.
50. Nicholson, RI, Bouzubar N, Walker KJ, McClelland R, Dixon AR, Robertson JF, Ellis IO & Blarney RW 1991. Hormone sensitivity in breast cancer influence of heterogeneity of receptor expression and cell proliferation on hormone sensitivity of breast cancer. European Journal of Cancer 27 908-913.
51. Noguchi M & Miyazaki I 1994 Prognostic factors in breast cancer and their controversies. Oncology Reports 1 1157-1163.
52. Offord EA, Leake RE & McNab JCM 1989 Stimulation of oestrogen receptor mRNA levies in MCF-7 cells by herpes simplex virus infection. Journal of Virology 63 2388-2391.
53. Rayter Z 1991 Steroid receptors in breast cancer. British Journal of Surgery 78 528-535.
54. Robertson JFR 1996 Prospective confirmation of a biochemical index for measuring therapeutic efficacy in metastatic breast cancer in a multicentre study. The Breast 5 372-373.
55. Rochefort H 1996 The prognostic value of Cathepsin D in breast cancer. A long road to the clinic. European Journal of Cancer 32 7-8.
56. Romain S, Laine Bidron C, Martin PM & Magdelenat H 1995 Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. European Journal of Cancer 31 411-417.
57. Shi RR, Key ME & Lalra KL 1991 Antigen retrieval in formalin fixed, paraffin embedded tissues, an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. Journal of Histochemistry and Cytochemistry 39 741-748.
58. Stewart HJ & Prescott R 1985 Adjuvant tamoxifen therapy and receptor levels. Lancet i 573.
59. Stewart JF, Rubens RD, Millis RR, King RJB & Hayward JL 1983 Steroid receptors and prognosis in operable (stage I and II) breast cancer. European Journal of Cancer and Clinical Oncology 19 1381-1387.
60. Thorpe S & Koenders A 1986 Standardisation of steroid receptor assays in human breast cancer III. Selection of reference material for intra- and inter-laboratory quality control. European Journal of Cancer and Clinical Oncology 22 939-944.
61. Thorpe S & Rose C 1986 Oestrogen and progesterone receptors in breast cancer. Cancer Surveys 5 505-525.
62. Toft D & Gorski J 1966 A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterisation. Proceedings of the National Academy of Sciences of the USA 55 1574-1581.
63. Walker KJ, McClelland RA, Candlish W, Blarney RW & Nicholson RI 1992 Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. European Journal of Cancer 28 34-37.
64. Westley BR & May FEB 1996 Cathepsin D and breast cancer. European Journal of Cancer 32 15-24.